应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DNLI Denali Therapeutics Inc.
盘前交易 05-13 08:51:45 EDT
18.31
-0.36
-1.93%
盘前
18.38
+0.07
+0.38%
08:00 EDT
最高
18.95
最低
18.27
成交量
76.32万
今开
18.84
昨收
18.67
日振幅
3.64%
总市值
26.11亿
流通市值
22.55亿
总股本
1.43亿
成交额
1,407万
换手率
0.62%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-新月能源、罗克韦尔自动化、Transdigm 集团
Reuters · 05-09
美国研究综述-新月能源、罗克韦尔自动化、Transdigm 集团
Denali Therapeutics Inc.盘中异动 急速上涨5.58%
自选股智能写手 · 05-08
Denali Therapeutics Inc.盘中异动 急速上涨5.58%
Denali Therapeutics Inc.盘中异动 股价大涨5.12%报17.67美元
自选股智能写手 · 05-03
Denali Therapeutics Inc.盘中异动 股价大涨5.12%报17.67美元
Denali Therapeutics Inc 预计每股亏损70美分 - 财报前瞻
Reuters · 05-03
Denali Therapeutics Inc 预计每股亏损70美分 - 财报前瞻
Denali Therapeutics Inc.盘中异动 快速跳水5.21%
自选股智能写手 · 04-25
Denali Therapeutics Inc.盘中异动 快速跳水5.21%
Denali Therapeutics Inc.盘中异动 早盘急速拉升5.07%报16.80美元
自选股智能写手 · 04-23
Denali Therapeutics Inc.盘中异动 早盘急速拉升5.07%报16.80美元
Denali Therapeutics Inc.盘中异动 急速下跌5.09%报18.45美元
自选股智能写手 · 04-10
Denali Therapeutics Inc.盘中异动 急速下跌5.09%报18.45美元
瑞银:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由70.00美元调整至32.00美元。
智通财经 · 04-10
瑞银:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由70.00美元调整至32.00美元。
Denali Therapeutics Inc.盘中异动 下午盘股价大涨5.03%报20.88美元
自选股智能写手 · 03-28
Denali Therapeutics Inc.盘中异动 下午盘股价大涨5.03%报20.88美元
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%
自选股智能写手 · 03-23
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%
Denali Therapeutics Inc.盘中异动 急速下挫5.17%
自选股智能写手 · 03-15
Denali Therapeutics Inc.盘中异动 急速下挫5.17%
Denali Therapeutics Inc.盘中异动 股价大跌5.03%
自选股智能写手 · 03-13
Denali Therapeutics Inc.盘中异动 股价大跌5.03%
Denali Therapeutics Inc.盘中异动 早盘快速上涨5.01%
自选股智能写手 · 03-01
Denali Therapeutics Inc.盘中异动 早盘快速上涨5.01%
BUZZ-Denali Therapeutics 完成 5 亿美元 PIPE 融资后大涨 30
Reuters · 02-28
BUZZ-Denali Therapeutics 完成 5 亿美元 PIPE 融资后大涨 30
Denali Therapeutics Inc盘中异动 急速拉升14.68%
自选股智能写手 · 02-27
Denali Therapeutics Inc盘中异动 急速拉升14.68%
Denali Therapeutics Inc 预计每股亏损80美分 - 财报前瞻
Reuters · 02-23
Denali Therapeutics Inc 预计每股亏损80美分 - 财报前瞻
美国研究综述-欧特克、Hireright Holdings、斑马技术公司
Reuters · 02-19
美国研究综述-欧特克、Hireright Holdings、斑马技术公司
嗡嗡声--美国股票走势-Super Micro Computer、Kinsale Capital、Kinnate Biopharma
Reuters · 02-16
嗡嗡声--美国股票走势-Super Micro Computer、Kinsale Capital、Kinnate Biopharma
Denali Therapeutics Inc盘中异动 早盘股价大跌5.12%报17.42美元
自选股智能写手 · 02-16
Denali Therapeutics Inc盘中异动 早盘股价大跌5.12%报17.42美元
加载更多
公司概况
公司名称:
Denali Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。
发行价格:
--
{"stockData":{"symbol":"DNLI","market":"US","secType":"STK","nameCN":"Denali Therapeutics Inc.","latestPrice":18.31,"timestamp":1715371200000,"preClose":18.67,"halted":0,"volume":763171,"hourTrading":{"tag":"盘前","latestPrice":18.38,"preClose":18.31,"latestTime":"08:00 EDT","volume":4,"amount":73.52,"timestamp":1715601600154},"delay":0,"floatShares":123158432,"shares":142609036,"eps":-0.976201,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.36,"latestTime":"05-13 08:51:45 EDT","open":18.84,"high":18.95,"low":18.27,"amount":14066431.313589,"amplitude":0.036422,"askPrice":21.03,"askSize":100,"bidPrice":18.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.976201,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715607000000},"adr":0,"listingDate":1512709200000,"adjPreClose":18.31,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":18.38,"preClose":18.31,"latestTime":"08:00 EDT","volume":4,"amount":73.52,"timestamp":1715601600154},"postHourTrading":{"tag":"盘后","latestPrice":18.31,"preClose":18.31,"latestTime":"16:20 EDT","volume":34848,"amount":638066.88,"timestamp":1715372400685},"volumeRatio":0.6012260687568763},"requestUrl":"/m/hq/s/DNLI/","defaultTab":"news","newsList":[{"id":"2434594580","title":"美国研究综述-新月能源、罗克韦尔自动化、Transdigm 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2434594580","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434594580?lang=zh_cn&edition=full","pubTime":"2024-05-09 14:54","pubTimestamp":1715237640,"startTime":"0","endTime":"0","summary":" 路透5月9日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,包括新月能源、罗克韦尔自动化和 Transdigm 集团。要闻 * 新月能源 :Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。* Transdigm Group Inc :摩根大通将目标价从1175美元上调至1350美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433729309","title":"Denali Therapeutics Inc.盘中异动 急速上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729309","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433729309?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:32","pubTimestamp":1715175154,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时32分,Denali Therapeutics Inc.股票出现异动,股价快速上涨5.58%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Repare Therapeutics Inc.、Adaptive Biotechnologies Corporation、内克塔治疗涨幅较大,Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为199.24%、25.15%、10.73%,振幅较大的相关个股有Adaptive Biotechnologies Corporation、Veru Inc.、Rani Therapeutics Holdings, Inc.,振幅分别为9.97%、9.20%、8.58%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132357a58c349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132357a58c349&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432702969","title":"Denali Therapeutics Inc.盘中异动 股价大涨5.12%报17.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432702969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432702969?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:35","pubTimestamp":1714743314,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时35分,Denali Therapeutics Inc.股票出现异动,股价急速上涨5.12%。截至发稿,该股报17.67美元/股,成交量3.6808万股,换手率0.03%,振幅3.45%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032135147a57fb42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032135147a57fb42&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432971221","title":"Denali Therapeutics Inc 预计每股亏损70美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432971221","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432971221?lang=zh_cn&edition=full","pubTime":"2024-05-03 20:43","pubTimestamp":1714740190,"startTime":"0","endTime":"0","summary":" * Denali Therapeutics Inc 预计将在5月6日公布截至2024年3月31日的业绩报告() 时显示季度收入下降。* 根据LSEG的数据,13位分析师的平均预期显示,这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的3514万美元下降60.1%,至1402.4万美元。* LSEG 分析师对 Denali Therapeutics Inc 的平均预期为每股亏损 70 美分。* 华尔街对 Denali Therapeutics Inc 的 12 个月目标价中位数为 35.50 美元,高于其上次收盘价 16.81 美元。5月3日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430898592","title":"Denali Therapeutics Inc.盘中异动 快速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430898592","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430898592?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:41","pubTimestamp":1714052496,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时41分,Denali Therapeutics Inc.股票出现波动,股价急速下跌5.21%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.37%。其相关个股中,Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大,Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃,换手率分别为1033.04%、187.71%、7.44%,振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达,振幅分别为40.85%、25.31%、14.75%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214136861e90ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214136861e90ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113793","title":"Denali Therapeutics Inc.盘中异动 早盘急速拉升5.07%报16.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113793?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:20","pubTimestamp":1713882046,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时20分,Denali Therapeutics Inc.股票出现异动,股价大幅拉升5.07%。截至发稿,该股报16.80美元/股,成交量17.4212万股,换手率0.12%,振幅4.69%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.34%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322204787e82da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322204787e82da1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426912384","title":"Denali Therapeutics Inc.盘中异动 急速下跌5.09%报18.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426912384","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426912384?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:32","pubTimestamp":1712755961,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时32分,Denali Therapeutics Inc.股票出现异动,股价急速下跌5.09%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.25%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。该信息摘要如下:瑞银:维持Denali Therapeutics评级,由买入调整至买入评级, 目标价由70.00美元调整至32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102132418b0a6fa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102132418b0a6fa2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426105581","title":"瑞银:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由70.00美元调整至32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426105581","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426105581?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:15","pubTimestamp":1712679310,"startTime":"0","endTime":"0","summary":"瑞银:维持Denali Therapeutics(DNLI.US)评级,由买入调整至买入评级, 目标价由70.00美元调整至32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410001512875aa6c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410001512875aa6c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422942414","title":"Denali Therapeutics Inc.盘中异动 下午盘股价大涨5.03%报20.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422942414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422942414?lang=zh_cn&edition=full","pubTime":"2024-03-28 02:43","pubTimestamp":1711565022,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日02时43分,Denali Therapeutics Inc.股票出现异动,股价快速上涨5.03%。截至发稿,该股报20.88美元/股,成交量22.4949万股,换手率0.16%,振幅5.18%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328024343861e1bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328024343861e1bd0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421082192","title":"Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421082192","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421082192?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:16","pubTimestamp":1711134991,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时16分,Denali Therapeutics Inc.股票出现异动,股价大幅下跌5.00%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Moolec Science Sa C/Wts 、Outlook Therapeutics, Inc.涨幅较大,Outlook Therapeutics, Inc.、Adial Pharmaceuticals, Inc、180 Life Sciences Corp.较为活跃,换手率分别为94.31%、54.59%、44.36%,振幅较大的相关个股有Virios Therapeutics, Inc.、Moolec Science Sa C/Wts 、Matinas Biopharma Holdings, Inc.,振幅分别为86.19%、75.83%、66.00%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303163287e7b1e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303163287e7b1e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419938602","title":"Denali Therapeutics Inc.盘中异动 急速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419938602","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419938602?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:28","pubTimestamp":1710437339,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时28分,Denali Therapeutics Inc.股票出现异动,股价急速下跌5.17%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.69%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,知临集团、Novabay Pharmaceuticals, Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为781.04%、178.10%、153.07%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团,振幅分别为110.40%、80.77%、76.91%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501290087e78fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501290087e78fec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419563305","title":"Denali Therapeutics Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419563305","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419563305?lang=zh_cn&edition=full","pubTime":"2024-03-13 01:16","pubTimestamp":1710263794,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日01时16分,Denali Therapeutics Inc.股票出现异动,股价急速下跌5.03%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Dermata Therapeutics Inc C/Wts 涨幅较大,Regulus Therapeutics Inc.、Tc Biopharm Plc、Scisparc Ltd.较为活跃,换手率分别为699.22%、317.10%、165.31%,振幅较大的相关个股有Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为131.16%、74.77%、66.13%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130116347a4bfec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130116347a4bfec2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416335644","title":"Denali Therapeutics Inc.盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416335644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416335644?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:49","pubTimestamp":1709304599,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时49分,Denali Therapeutics Inc.股票出现异动,股价大幅上涨5.01%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.09%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Carmell Corp C/Wts 12/07/2028 涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃,换手率分别为2389.45%、252.23%、96.84%,振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Biovie Inc.、Adial Pharmaceuticals, Inc,振幅分别为71.25%、69.35%、60.29%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500087e75454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500087e75454&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414389504","title":"BUZZ-Denali Therapeutics 完成 5 亿美元 PIPE 融资后大涨 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2414389504","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414389504?lang=zh_cn&edition=full","pubTime":"2024-02-28 02:46","pubTimestamp":1709059567,"startTime":"0","endTime":"0","summary":" 2月27日 - ** Denali Therapeutics Inc 通过私募融资后,该公司股价周二大涨31%至22.13美元,创今年最高水平** 股价有望创下2020年8月以来最大单日涨幅** DNLI 表示, ,将以 17.07 美元的价格出售约 2970 万股股票,包括约 2600 万份预先筹资的认股权证,在 PIPE,募集资金 5 亿美元。** 该公司表示,截至 12 月底,公司拥有约 10 亿美元现金,并称预计 PIPE 募集资金将使公司的现金流延长至 2028 年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414803983","title":"Denali Therapeutics Inc盘中异动 急速拉升14.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414803983","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414803983?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:31","pubTimestamp":1709044315,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时31分,Denali Therapeutics Inc股票出现异动,股价大幅拉升14.68%。Denali Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃,换手率分别为305.15%、83.32%、29.58%,振幅较大的相关个股有Viking Therapeutics Inc、Fate Therapeutics、Janux Therapeutics Inc,振幅分别为21.70%、17.84%、14.57%。Denali Therapeutics Inc公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272231558ae6ec99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272231558ae6ec99&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413898751","title":"Denali Therapeutics Inc 预计每股亏损80美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413898751","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413898751?lang=zh_cn&edition=full","pubTime":"2024-02-23 19:08","pubTimestamp":1708686534,"startTime":"0","endTime":"0","summary":" * Denali Therapeutics Inc 将于2月26日公布截至2023年12月31日的财报,预计(),季度收入将出现下降。* 根据LSEG的数据,14位分析师的平均预期显示,这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的1028万美元下降18.7%,至836.5万美元。* LSEG 分析师对 Denali Therapeutics Inc 的平均预期是每股亏损 80 美分。* 华尔街对 Denali Therapeutics Inc 的 12 个月目标价中位数为 39.00 美元,高于其上次收盘价 16.83 美元。2月23日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412972660","title":"美国研究综述-欧特克、Hireright Holdings、斑马技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2412972660","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412972660?lang=zh_cn&edition=full","pubTime":"2024-02-19 14:40","pubTimestamp":1708324852,"startTime":"0","endTime":"0","summary":" 路透社2月19日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Autodesk、Hireright Holdings 和斑马技术公司。要闻 * 欧特克公司 :贝伦贝格将目标价从250美元上调至290美元 * Hireright Holdings Corp :Needham将目标价从 \"买入 \"下调至 \"持有 * 斑马技术公司 :Baird将目标价从292美元上调至312美元 以下是路透社周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411566281","title":"嗡嗡声--美国股票走势-Super Micro Computer、Kinsale Capital、Kinnate Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2411566281","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411566281?lang=zh_cn&edition=full","pubTime":"2024-02-16 23:53","pubTimestamp":1708098808,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月16日 - 周五,华尔街主要股指走低,此前一份热度高于预期的生产者物价报告打压了市场对美国联邦储备委员会 即将降息的猜测。美东时间10:31,道琼斯工业平均指数 下跌0.27%,报38,669.2点。标准普尔500指数 下跌0.39%,报5,010.17点;纳斯达克综合指数 下跌0.75%,报15,787.267点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411866548","title":"Denali Therapeutics Inc盘中异动 早盘股价大跌5.12%报17.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411866548","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411866548?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:31","pubTimestamp":1708093894,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日22时31分,Denali Therapeutics Inc股票出现波动,股价大幅下挫5.12%。截至发稿,该股报17.42美元/股,成交量9.5481万股,换手率0.07%,振幅2.75%。Denali Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.01%。Denali Therapeutics Inc公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402162231347911c543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402162231347911c543&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.denalitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0683},{"period":"1month","weight":-0.006},{"period":"3month","weight":0.0144},{"period":"6month","weight":0.1289},{"period":"1year","weight":-0.3388},{"period":"ytd","weight":-0.1468}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.022693},{"month":2,"riseRate":0.428571,"avgChangeRate":0.015921},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.073957},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.018616},{"month":5,"riseRate":0.857143,"avgChangeRate":0.081169},{"month":6,"riseRate":0.5,"avgChangeRate":0.02869},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.067919},{"month":8,"riseRate":0.5,"avgChangeRate":0.072065},{"month":9,"riseRate":0.5,"avgChangeRate":0.005452},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.051994},{"month":11,"riseRate":0.666667,"avgChangeRate":0.156372},{"month":12,"riseRate":0.5,"avgChangeRate":0.070849}],"exchange":"NASDAQ","name":"Denali Therapeutics Inc.","nameEN":"Denali Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Denali Therapeutics Inc.,DNLI,Denali Therapeutics Inc.股票,Denali Therapeutics Inc.股票老虎,Denali Therapeutics Inc.股票老虎国际,Denali Therapeutics Inc.行情,Denali Therapeutics Inc.股票行情,Denali Therapeutics Inc.股价,Denali Therapeutics Inc.股市,Denali Therapeutics Inc.股票价格,Denali Therapeutics Inc.股票交易,Denali Therapeutics Inc.股票购买,Denali Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}